As a recognized leader in the contract research organization (CRO) industry for conducting complex Phase 1 trials, PharPoint Research has contributed expert services critical to the approval of many important drugs. PharPoint Research has participated in 327 Phase 1 studies in many therapeutic areas and indications, including infectious disease, oncology, central nervous system (CNS), nephrology, and endocrinology. Our significant Phase 1 experience encompasses 94 indications. We have provided biostatistics and data management services for dozens of these Phase 1 trials. PharPoint is a full service CRO that provides support for clinical trials at every level and phase. Our network of best in class expertise allows us to provide an accomplished service for Phase 1 studies of all types.
About the Author
Expanded Consulting Services
We recently expanded our consulting services in response to a growing need from clients. Read the full release here.